In AML1-ETO (AE)-driven AML, phospholipase C gamma 1 (PLCG1) is an AE fusion protein-specific target that is increased after binding of AE to intergenic modulatory DNA elements.168. Here, RUNX1T1 is linked to acute myeloid leukemia.